Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
37.33
+1.16 (3.21%)
Jul 9, 2026, 4:00 PM EDT - Market closed
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $1.02 billion as of July 10, 2026. Its market cap has increased by 180.58% in one year.
Market Cap
1.02B
Enterprise Value
1.03B
1-Year Change
180.58%
Ranking
Category
Stock Price
$37.33
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $1.02B, an increase of 867.05%. That is a compound annual growth rate of 34.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.02B | 125.49% |
| Dec 31, 2025 | 453.48M | 27.82% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.47B |
| Phibro Animal Health | 1.37B |
| Collegium Pharmaceutical | 1.22B |
| Alvotech | 1.21B |
| BioAge Labs | 1.06B |
| Evotec SE | 1.05B |
| Cronos Group | 1.02B |
| Pacira BioSciences | 1.02B |